Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

KURUME UNIVERSITY

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: Private

Established: 1930-01-01

Employees: 1K

Market Cap: -

Website: http://www.kurume-u.ac.jp

Clinical Trials

An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia

Phase 4

Completed

Conditions: Insomnia

Interventions: Drug: Lemborexant (LEM) 5 mg (SUV-mono cohort)
Drug: Lemborexant (LEM) 5 mg (Z-Drug-mono cohort)
Drug: Lemborexant (LEM) 5 mg (SUV-combination cohort)
Drug: Lemborexant (LEM) 5 mg (RMT-combination cohort)

First Posted Date: 2021-02-08

Last Posted Date: 2023-03-15

Lead Sponsor: Kurume University

Target Recruit Count: 97

Registration Number: NCT04742699

Locations: 🇯🇵
YOU ARIYOSHI Sleep Clinic, Kitakyushu, Fukuoka, Japan
🇯🇵
Kurume University Hospital, Kurume, Fukuoka, Japan
🇯🇵
Hirota Clinic, Kurume, Fukuoka, Japan

and more 6 locations

Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue

Phase 4

Conditions: Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension

Interventions: Drug: Amlodipine
Drug: Olmesartan

First Posted Date: 2016-12-19

Last Posted Date: 2016-12-20

Lead Sponsor: Kurume University

Target Recruit Count: 100

Registration Number: NCT02996916

Locations: 🇯🇵
Kurume University Hospital, Kurume, Japan

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Phase 4

Conditions: Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications

Interventions: Drug: DPP-4 inhibiotors
Drug: SGLT2 inhibitors
Drug: Glimepiride

First Posted Date: 2015-08-19

Last Posted Date: 2015-08-19

Lead Sponsor: Kurume University

Target Recruit Count: 100

Registration Number: NCT02528019

Locations: 🇯🇵
Kurume University Hospital, Kurume city, Japan

Effects of Montelukast on Airway Regulatory T Cells in Asthma

Phase 2

Conditions: Asthma

Interventions: Drug: Montelukast

First Posted Date: 2013-09-27

Last Posted Date: 2013-09-27

Lead Sponsor: Kurume University

Target Recruit Count: 15

Registration Number: NCT01951898

Locations: 🇯🇵
Kurume University School of Medicine, Kurume, Japan

Pioglitazone Decreases Visceral Fat Metabolism

Not Applicable

Conditions: To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging

Interventions: Drug: Pioglitazone vs Glimepiride

First Posted Date: 2013-03-27

Last Posted Date: 2013-03-27

Lead Sponsor: Kurume University

Target Recruit Count: 60

Registration Number: NCT01819402

Locations: 🇯🇵
Kurume University, Kurume, Japan

Cardiac Sarcoidosis and FDG-PET

Completed

Conditions: Sarcoidosis
Dilated Cardiomyopathy

First Posted Date: 2009-08-13

Last Posted Date: 2012-09-27

Lead Sponsor: Kurume University

Target Recruit Count: 20

Registration Number: NCT00958087

Locations: 🇯🇵
Kurume University Hospital, Kurume city, Japan

Morning Hypertension and Preminent Therapy Study

Phase 4

Completed

Conditions: Hypertension

Interventions: Drug: Preminent (losartan/hydrochlorothiazide combination drug)

First Posted Date: 2008-11-21

Last Posted Date: 2011-06-23

Lead Sponsor: Kurume University

Target Recruit Count: 216

Registration Number: NCT00795847

Locations: 🇯🇵
Cardio-vascular Medicine, Kurume University, Kurume, Fukuoka, Japan

Relation of Circulating Endothelium-derived Microparticle to Carotid Atherosclerosis

Completed

Conditions: Atherosclerosis

First Posted Date: 2008-11-21

Last Posted Date: 2015-03-31

Lead Sponsor: Kurume University

Target Recruit Count: 154

Registration Number: NCT00795067

Locations: 🇯🇵
Kurume University Hospital, Kurume, Fukuoka, Japan

Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle

Early Phase 1

Completed

Conditions: Atherosclerosis

Interventions: Behavioral: smoking cessation

First Posted Date: 2008-11-21

Last Posted Date: 2011-06-23

Lead Sponsor: Kurume University

Target Recruit Count: 100

Registration Number: NCT00795249

Locations: 🇯🇵
Kurume University Hospital, Kurume, Fukuoka, Japan

Anti-Inflammatory Effects of Pioglitazone

Not Applicable

Completed

Conditions: Impaired Glucose Tolerance
Type 2 Diabetes Mellitus
Atherosclerosis

Interventions: Drug: Pioglitazone
Drug: Glimepiride

First Posted Date: 2008-07-25

Last Posted Date: 2012-09-27

Lead Sponsor: Kurume University

Target Recruit Count: 70

Registration Number: NCT00722631

Locations: 🇯🇵
Kurume University Hospital, Kurume city, Japan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy